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ABSTRACT 
 
Objective 
To assess whether 64-slice computed tomography (CT) angiography might replace some 
coronary angiography (CA) for diagnosis and assessment of coronary artery disease (CAD).   
 
Methods  
We searched electronic databases, conference proceedings and scanned reference lists of 
included studies.  Eligible studies compared 64-slice CT with a reference standard of CA in 
adults with suspected/known CAD, reporting sensitivity and specificity or true and false 
positives and negatives.  Data were pooled using the hierarchical summary receiver operating 
characteristic model.  
 
Results 
Forty studies were included; 28 provided sufficient data for inclusion in the meta-analyses, all 
using a cutoff of ≥ 50% stenosis to define significant CAD.  In patient-based detection 
(n=1286) 64-slice CT pooled sensitivity was 99% (95% credible interval (CrI) 97 to 99%), 
specificity 89% (95% CrI 83 to 94%), median positive predictive value (PPV) across studies 
93% (range 64 to 100%) and negative predictive value (NPV) 100% (range 86 to 100%). In 
segment-based detection (n=14,199) 64-slice CT pooled sensitivity was 90% (95% CrI 85 to 
94%), specificity 97% (95% CrI 95 to 98%), median positive predictive value (PPV) across 
studies 76% (range 44 to 93%) and negative predictive value (NPV) 99% (range 95 to 100%).   
 
Conclusions 
64-slice CT is highly sensitive for patient-based detection of CAD and has high NPV. An 
ability to rule out significant CAD means that it may have a role in the assessment of chest 
pain, particularly when the diagnosis remains uncertain despite clinical evaluation and simple 
non-invasive testing. 
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INTRODUCTION 
 
Coronary artery disease (CAD) is a major cause of mortality and ill health, causing an 
estimated 7.6 million deaths globally in 2005.[1]  In the United Kingdom it causes around 
101,000 deaths each year[2] and is the most common cause of death.  Currently, invasive 
coronary angiography (CA) is regarded as the ‘gold standard’ for the assessment of coronary 
anatomy.  However, conventional CA has limitations.  It is an invasive procedure with a small 
(0.1 to 0.2%) risk of major complications[3] and affords information only on the site and 
degree of luminal narrowing – providing no data on the extent of atherosclerotic change 
within the vessel wall.  Images are obtained in only two dimensions – though the use of 
multiple projections enables a more comprehensive assessment of any individual lesion.  
Finally, there are constraints on the amount of CA that can be undertaken, both in terms of 
infrastructure and cardiologist time.  An accurate non-invasive test for diagnosing CAD that 
could potentially avoid the need for some CA is, therefore, highly desirable. 
Multislice computed tomography (MSCT) has been developing rapidly in recent 
years.  Four-slice machines appeared in 1998, 16-slice in 2001 and 64-slice in 2004.  This has 
resulted in greatly increased temporal and spatial resolution[4] – facilitating the rapid 
identification and assessment of atherosclerosis within the moving coronary arteries[5,6] and 
generating considerable interest in the concept that MSCT might potentially reduce the need 
for invasive CA. The aim of this systematic review was to assess the accuracy of 64-slice CT 
angiography compared with conventional CA in the diagnosis and assessment of CAD.   
 
METHODS 
 
Search strategy  
Highly sensitive search strategies were developed using both appropriate subject headings and 
text word terms.  Full details of the search strategies used are available from the authors.  We 
searched the following electronic databases: Medline (2002 – November Week 3 2006), 
Embase (2002 to December 2006), Biosis (2002 to December 2006), Science Citation Index 
(2002 – December 2006), Medline In-Process (14th December 2005), Cochrane Controlled 
Trials Register (The Cochrane Library, Issue 4 2006), Cochrane Database of Systematic 
Reviews (The Cochrane Library, Issue 4, 2006), Database of Abstracts of Reviews of 
Effectiveness (December 2006), HTA Database (December 2006) and Health Management 
Information Consortium (2002 – May 2006). In addition, recent conference proceedings and 
reference lists of all included studies were scanned to identify additional potentially relevant 
studies.  Searches were from 2002 onwards and restricted to English language reports.  
 
Inclusion criteria 
We included randomised controlled trials (RCTs), non-randomised comparative studies or 
case series involving adults with suspected or known CAD.  The index test was 64-slice CT 
angiography compared with conventional CA as the reference standard.  Studies had to report 
sensitivity and specificity or true and false positives and negatives. 
 
Data extraction 
One reviewer screened the titles (and abstracts if available) of all reports identified by the 
search strategy.  Full copies of potentially relevant reports were obtained and two reviewers 
independently assessed them for inclusion.  Data were extracted independently by two 
reviewers.  Disagreements were resolved by consensus or arbitration by a third reviewer.   
 
Quality assessment 
Two reviewers independently assessed the methodological quality of full text studies using 
QUADAS[7] which was modified to make it more applicable to studies for diagnosing and 
assessing CAD.  Three questions in the original QUADAS tool that related to the quality of 
reporting rather than methodological quality were excluded (questions 2, 8 and 9).  Three 
questions were added on (a) whether an established cutoff point was used (question 12), (b) 
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whether data on observer variation were reported and within an acceptable range (question 
13) and (c) whether data were presented for appropriate subgroups of patients (question 14).  
Disagreements were resolved by consensus or arbitration by a third reviewer.     
 
Statistical analysis 
Where three or more studies reported data, summary receiver operating characteristic (SROC) 
curves were derived for the following levels of analysis: patient, segment, artery (left main, 
proximal left anterior descending (LAD), any LAD, left circumflex (LCX), right coronary 
artery (RCA)), stent and coronary artery bypass graft (CABG).  The meta-analysis method 
used was the hierarchical summary receiver operating characteristic (HSROC) model,[8] 
fitted using WinBUGS 1.4.[9]  A symmetric SROC model was used to address the lack of 
numerical convergence of the full SROC model.  Pooled estimates for sensitivity and 
specificity were reported as medians and 95% credible intervals (CrIs), the Bayesian 
equivalent of confidence intervals (CIs).      
If numerical difficulties were encountered with the symmetric HSROC model and 
there was also no evidence of heterogeneity, sensitivity and specificity were pooled using the 
weighted average method.[10]  These analyses were carried out using Metadisc software[11] 
and corresponding 95% confidence intervals (CIs) (rather than CrIs) were reported.  This 
approach was required for the left main artery analysis.  Heterogeneity was assessed using the 
I2 statistic in Metadisc software,[11] with a value greater than 50% considered to represent 
substantial heterogeneity.[12] 
 
RESULTS 
 
Figure 1 shows the flow of studies through the review.  Out of a total of 1211 titles/abstracts 
screened, 275 were selected as potentially relevant and full papers obtained where possible.  
Forty studies (21 full text, [13-33] 19 abstracts [34-52]), published in 67 reports, met the 
inclusion criteria.  All were non-randomised studies comparing 64-slice CT with a reference 
standard of invasive CA.   
 
[Figure 1 Flow of studies through review process] 
 
The characteristics of the included studies are available as online content, linked to 
the online manuscript.  The 40 studies involved more than 2400 people.  In 25 studies 
reporting gender 67% (n=1184) of participants were men.  Across 27 studies reporting mean 
age this ranged from 54 to 69 years (median 61 years).  Most studies reported elective 
assessment for CAD, with study populations including those with suspected CAD, known 
CAD, or both.  In addition the following specific groups were studied: patients with previous 
PCI or CABG and those with a suspected acute coronary syndrome.   
All studies used 64-slice CT angiography.  Most studies (n=28) used Siemens 
Sensation 64 machines; other types of equipment used included GE Healthcare Light-Speed 
VCT (n=2), Philips Brilliance 64 (n=2) and Toshiba Multi-Slice Aquilion 64 (n=1).   
The quality assessment for the 21 full text studies is summarised in Figure 2.  In all 
studies conventional CA was the reference standard, results were abstracted only if patients 
received both 64-slice CT angiography and the reference standard (partial verification bias 
avoided), patients received the same reference standard (differential verification bias avoided) 
and the index test did not form part of the reference standard (incorporation bias avoided).  In 
85% of studies those interpreting 64-slice CT data were blinded to the results of the reference 
standard test (test review bias avoided) and in 71% of studies vice versa (diagnostic review 
bias avoided).  In 48% of studies the participants belonged to specific groups (spectrum bias), 
for example those with previous revascularisation. 
 
[Figure 2 Results of the quality assessment of the 21 full text studies] 
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Twenty-eight studies provided sufficient data (true positives, false positives, false 
negatives, true negatives) to allow their inclusion in the meta-analyses, although the number 
of studies included for each level of analysis varied (see Table 1).  The pooled estimates for 
the sensitivity and specificity of 64-slice CT angiography for detecting significant CAD for 
each level of analysis are shown in Figure 3 (also available in a table as online content linked 
to the online manuscript).  Across studies the median PPV and NPV along with their ranges 
for each level of analysis are shown in Figure 4 (also available in a table as online content 
linked to the online manuscript).  All studies used a cut-off of > 50% or ≥ 50% stenosis to 
define significant CAD.  
Table 1 Studies included in the pooled estimates for different levels of analysis 
 
Level of analysis  
Study id Patient Segment Left main 
artery 
LAD artery Proximal 
LAD artery 
LCX artery RCA Stent CABG 
 Full text studies 
Ehara 2006a[13]                 
Ghostine 2006[15]                 
Hoffmann 2006[16]           
Leber 2005[18]            
Leschka 2005[19]                
Meijboom 2006[20]               
Mollet 2005[21]            
Nikolaou 2006[22]                
Ong 2006[23]                
Pache 2006[24]            
Plass 2006[25]            
Pugliese 2006a[26]                
Raff 2005[27]            
Rist 2006[28]           
Rixe 2006[29]           
Ropers 2006a[30]            
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Level of analysis  
Study id Patient Segment Left main 
artery 
LAD artery Proximal 
LAD artery 
LCX artery RCA Stent CABG 
Ropers 2006b[31]             
Schuijf 2006[32]             
 Abstracts 
Becker 2006[35]           
Ehara 2006b[36]           
Hausleiter 2005[38]           
Malagutti 2006[41]            
Oncel 2006[42]           
Onuma 2006[43]           
Rubinshtein 
2006a[47] 
          
Rubinshtein 
2006b[48] 
          
Savino 2006[49]            
Schlosser 2006[50]           
 
Notes: 
1.  LAD, left anterior descending; LCX, left circumflex; RCA, right coronary artery; CABG, coronary artery bypass graft.   
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 [Figure 3 Pooled estimates (95% CrI) for different levels of analysis] 
 [Figure 4 Median positive and negative predictive values across studies (range)] 
 
Patient and segment based analyses 
In 18 studies (n=1286) 64-slice CT was extremely sensitive in patient-based detection of 
CAD, with a pooled sensitivity of 99% (95% CrI 97 to 99%).  Specificity was lower at 89% 
(95% CrI 83 to 94%).  The median NPV across studies was very high at 100% (range 86 to 
100%), while PPV was 93% (range 64 to 100%).  The wide range of PPVs is probably due to 
the studies being heterogeneous in terms of their populations and the prevalence of significant 
CAD (median across studies 58%, range 23 to 96%).  The median false positive rate across 
studies was 10% (range 0 to 50%), representing an overestimation of the presence of non-
significant stenosis as significant, as opposed to finding CAD where none existed.  There was 
very low statistical heterogeneity in terms of sensitivity (I2=0.1%) and moderate statistical 
heterogeneity in terms of specificity (I2=31.7%).  In 17 studies reporting coronary artery 
segment-based detection (n=14,199), compared with patient-based detection, pooled 
sensitivity was lower (90%, 95% CrI 85 to 94%), specificity higher (97%, 95% CrI 95 to 
98%), median PPV lower (76%, range 44 to 93%) and NPV similar (99%, range 95 to 100%). 
 Five of 18 studies in the pooled estimates for patient-based detection of CAD, and 
three of 17 for segment-based detection, were abstracts. A sensitivity analysis undertaken to 
examine the effect of removing abstracts from the pooled estimates found that this did not 
affect the results. For patient-based detection sensitivity (95% CrI) remained unchanged at 
99% (97 to 99%), while specificity increased slightly to 91% (84 to 95%). For segment-based 
detection sensitivity also remained unchanged at 90% (84 to 94%), while specificity 
decreased slightly to 96% (95% CrI 94 to 98%).     
 
Artery level analyses 
At artery level pooled sensitivity and specificity were both highest for the left main artery 
(95% (95% CI 84 to 99%); 100% (95% CI 99 to 100%) respectively).  Pooled sensitivity was 
lowest for the LCX at 85% (95% CrI 69 to 94%).  Pooled specificity estimates for all of the 
arteries were very high at ≥ 96%.  Across studies the median PPV and NPV were also both 
highest for the left main artery (100%, range 90 to 100%; 100% (all five studies) 
respectively).  The median NPVs for all of the arteries were very high at ≥ 98% (ranges: LAD 
95 to 100%; LCX 93 to 100%; RCA 94 to 100%).  The median PPV was lowest for the LCX 
(81%, range 56 to 100%).   
 
Specific subgroups 
In six studies reporting patency of stents (n=317), with a cutoff > or ≥ 50% in-stent restenosis 
defining a positive test result, sensitivity was 89% (95% CrI 68 to 97%) and specificity 94% 
(95% CrI 83 to 98%), while across studies the median PPV was 77% (range 33 to 100%) and 
NPV was 96% (range 71 to 100%).  Stents caused some problems for 64-slice CT.  Leber and 
colleagues[18] reported that, of nine stents without any restenosis on conventional CA, four 
were false positives on 64-slice CT due to artifacts caused by the dense stent material.  
Importantly, the utility of CT angiography appears to be greatly influenced by the diameter 
and strut-thickness of the stent.[29]  In three studies[28,29,36] 21% (59/276) of stents were 
classed as unevaluable and excluded from analysis, while the remaining three studies did not 
report this information. 
Four studies reported patency of bypass grafts (n=543).  Both sensitivity and 
specificity were very high (99%, 95% CrI 95 to 100%; 96%, 95% CrI 86 to 99% 
respectively), while across studies the median PPV was 93% (range 90 to 95%) and NPV was 
very high at 99% (range 98 to 100%). 
Only three studies[16,35,46] assessed the diagnostic performance of 64-slice CT in 
patients admitted to hospital with suspected acute coronary syndromes (n=232).  Across these 
studies the median (range) values were 100% (97 to 100%) for sensitivity, 100% (79 to 
100%) for specificity, 100% (87 to 100%) for PPV and 100% (94 to 100%) for NPV.    
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Technical limitations 
Scans could not be adequately evaluated in 2% (11/718) of patients (n=13 studies), 8% 
(997/12,476) of all arterial segments, 21% (59/276) of stented segments (n=3 studies) and 0% 
(0/231) of bypass grafts (n=2 studies).  Three percent (11/404) of scans of the left main artery, 
5% (74/1641) of the RCA and 6% of both the LAD (104/1789) and the LCX (93/1444) could 
not be evaluated.  Studies reported that poor image quality was caused by factors including 
irregular heart rhythm, sinus tachycardia > 90/min, calcification, vessel motion or small 
vessel calibre in distal segments. 
It is unclear to what extent the exclusion or otherwise of small diameter vessels 
affected 64-slice CT performance as only seven studies provided this information, with 
five[19,23,25,30,31] excluding segments < 1.5 mm in diameter from analysis and two[20,27] 
analysing all vessels regardless of size.  Across the five studies excluding segments < 1.5 mm 
the median sensitivity was 87% (range 85 – 94%) and specificity 96% (range 76 – 97%) 
compared with median sensitivity of 90% (range 86 – 94%) and specificity of 96.5% (range 
95 – 98%) for the two studies analysing all segments. 
Coronary artery calcification may make scans more difficult to interpret.  Ghostine 
and colleagues[15] noted that heavily calcified segments accounted for 21 (81%) of 26 false 
negative results.  In the study by Raff and colleagues[27] the false positive rate increased as 
calcification became more severe, with a 2% (14/709) false positive rate in segments rated as 
‘no calcification’, 6% (5/89) in those rated as ‘mild’, 13% (6/48) in those rated as ‘moderate’ 
and 18% (16/88) in those segments rated as ‘severe’.   
 
DISCUSSION 
 
The current study suggests that 64-slice CT angiography is highly sensitive for patient-based 
detection of significant CAD (≥ 50% stenosis), with a very high NPV.   This high NPV was 
also apparent in analyses based on individual coronary arteries and segments.  At artery level 
the best results for 64-slice CT were in those arteries such as left main and LAD where 
significant CAD carries the poorest prognosis.  Based on a few small studies, broadly similar 
results were demonstrated in patients who had undergone prior coronary artery stenting, 
CABG and those with a suspected acute coronary syndrome. 
 
Prior studies 
We did not identify any other published systematic reviews focusing on 64-slice CT.  Several 
systematic reviews of MSCT[5,6,53-55] included 64-slice CT studies, all of which are 
included in our review.  A systematic review by Stein and colleagues[5] of multidetector (4-
slice and higher) CT for the diagnosis of CAD identified one 64-slice CT study by Leschka 
and colleagues.[19] The authors concluded that the preliminary data with 64-slice CT 
suggested that it was more sensitive and specific than 16-slice CT, and that multidetector CT 
had the potential to be used as a screening test in appropriate patients.  The USA Technology 
Evaluation Center[6] (a subsidiary of the private providers Blue Cross and Blue Shield), in a 
review of CT angiography (32-slice or higher) identified six 64-slice CT 
studies.[18,19,21,26,27,30] The authors reported that in patient-based analysis the 64-slice CT 
studies showed high sensitivities and specificities compared with the reference standard of 
conventional coronary angiography.[6]  A technology assessment by Patel and 
colleagues,[54] undertaken for the USA Medicare Coverage Advisory Commission included 
CT angiography (16-slice or higher) and identified six 64-slice CT 
studies.[18,19,21,26,27,30,37] The authors concluded that the sensitivity and specificity of 
64-slice CT in patient-based analysis looked promising.[54] Systematic reviews and meta-
analyses by Sun and colleagues[55] (4-slice or higher) and Hamon and colleagues[53] (16-
slice or higher) identified seven[18,19,21,26,27,30,37] and nine[13,18,19,21,22,26,27,30,32] 
64-slice CT studies respectively. Both reviews undertook meta-analyses at patient, vessel and 
segment level, although neither presented separate pooled estimates for the group of 64-slice 
CT studies. In patient-based analysis Sun and colleagues[55] reported pooled estimates (95% 
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confidence interval (CI)) of 91% (88 to 95%) sensitivity and 86% (81 to 92%) specificity. The 
authors concluded that diagnostic accuracy was significantly improved with 64-slice scanners 
compared with 4- and 16-slice scanners.[55] In patient-based analysis Hamon and 
colleagues[53] reported pooled estimates (95% CI) of 96% (94 to 98%) sensitivity and 74% 
(65 to 84%) specificity. The authors concluded that MSCT had shortcomings difficult to 
overcome in daily practice, with continuing moderate specificity in patient-based analysis in 
patients with high prevalence of CAD. They stated that studies evaluating the diagnostic 
performance of the newest-generation MSCT, including patients with low to moderate CAD 
prevalence, would be critical in establishing the clinical role of this emerging technology as 
an alternative to CA.[53]   
 
Radiation doses 
Although CT is regarded as non-invasive, it delivers a higher radiation dose than conventional 
CA and concerns have been raised about indiscriminate or repetitive use and, in particular, the 
risks in younger individuals or women of childbearing age.[56]  Hausleiter and colleagues[57] 
reported an effective radiation dose of 11.0 (SD 4.1) mSv for 64-slice CT.  By comparison 
estimates of mean effective doses for conventional CA include < 5 mSv by a British 
Cardiovascular Society Working Group,[58] and 4 to 8 mSv by the Technology Evaluation 
Center.[59]  In this review six studies[15-18,22,28] reported 64-slice CT radiation dose for 
the patient population as a whole and six[20,21,26,27,30,31] reported it separately for men 
and women.  The radiation dose for men ranged from 7.5 mSv[30] to 15.2 mSv[20,21] and for 
women from 10.2 mSv[31] to 21.4 mSv.[20,21]  Two[30,31] of these studies using ECG-
controlled dose modulation to reduce the tube current during systole reported the lowest 
radiation doses: 7.5 mSv[30] and 8.6 mSv[31] for men and 10.2 mSv[30] and 12.2 mSv[31] 
for women. One study[19] used an alternative technique, automatic exposure control,[60] to 
reduce radiation dose exposure but did not report the actual dosage values that the patients 
received. With the development of more modern technologies and methods, it may be 
possible to reduce the radiation dose further. Einstein and colleagues[61] have estimated that 
a single 64-slice CT study would result in an increase in lung cancer and breast cancer risk, 
especially if used in younger patients (for example a lifetime attributable cancer risk of 1 in 
114 after a combined heart and aortic scan in a 20-year old woman, compared to 1 in 715 for 
a 60-year old woman, with risks reduced by ECG controlled modulation). 
 
Strengths and limitations 
The current review included both full text studies and conference abstracts in an attempt to 
obtain the latest available data.  All studies used the same reference standard of conventional 
CA and only data for those who received both index test and reference standard were included 
in the meta-analyses.  A limitation was that non-English language studies were excluded.  No 
adjustment was made for studies which used multiple samples from each participant for some 
levels of analysis.  
 
Implications for practice 
Given the high sensitivity and negative predictive value, the main role of MSCT may be to 
rule out significant CAD, and thereby reduce the need for invasive CA.  There are several 
clinical situations where this may be particularly useful. In patients with a very low 
probability of CAD it is unlikely that MSCT would be recommended, particularly given the 
radiation doses involved. Likewise, when the probability of CAD is high conventional 
angiography is likely to remain the investigation of choice in the majority of patients. 
However, very many patients fall into an intermediate category where the diagnosis of CAD 
remains uncertain following clinical assessment and simple non-invasive testing. Currently, 
this may necessitate either myocardial perfusion scanning or invasive CA. It seems likely that 
MSCT may have an increasing role in this setting.  
There are other specific settings where MSCT may be of particular value. For 
example, in patients with acute chest pain a test with the capacity to rapidly and effectively 
rule out significant CAD – or provide a definitive diagnosis - has obvious potential. The 
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limited data currently available suggest that this may indeed be the case.[62] In patients with a 
history of CABG invasive angiography may be more technically difficult, time-consuming 
and associated with higher radiation doses. MSCT may, therefore, have some advantages in 
selected patients following surgical revascularisation. Likewise, many patients who are 
scheduled to undergo surgery for valvular heart disease and other non-coronary cardiac 
conditions currently undergo ‘routine’ invasive angiography – much of which might be 
replaced by MSCT.[20,63]    
 
Conclusion 
Although further work is required to determine the prognostic utility of MSCT and to clarify 
its precise clinical role, the currently available data suggest that it will play an increasing role 
in the evaluation of patients with known or suspected CAD. The technology continues to 
evolve and data are awaited on the marginal costs and benefits of the next generation of 
MSCT, the 256 and higher-slice CT machines. 
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Figure 2 Results of the quality assessment of the 21 full text studies 
 
Notes: 
1. The question on ‘partial verification bias avoided’ was checked ‘Yes’ for two studies 
(16,17) in which only some patients received both index and reference standard tests.  For 
these two studies only the results for the patients who received both tests were included in 
the review. 
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Figure 3 Pooled estimates (95% CrI) for different levels of analysis   
 
Notes: 
1. Left main artery: due to numerical difficulties with the HSROC symmetric model, 
sensitivity and specificity were pooled using the weighted average method and confidence 
intervals rather than credible intervals were reported. 
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Figure 4 Median positive and negative predictive values across studies (range) 
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Supplementary material Table 1 Characteristics of the included studies 
 
(a) Full text  
 
Study id, country Participants 64-slice CT Outcomes summary 
Ehara 2006a[13] 
 
Country: Japan 
Enrolled: 69  
Analysed: 67 
Age (years): Mean 67, SD 11 
Sex: M 52; F 17 
Prevalence of significant CAD: 
88% (61/69) 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: N/S  
 
  
Segments (n=884), patients (n=67)  
Cutoff: > 50% stenosis  
Sensitivity: 90%, 98%  
Specificity: 94%, 86%  
PPV: 89%, 98%  
NPV: 95%, 86%  
 
Fine 2006a[14] 
 
Country: USA 
Enrolled: 66  
Analysed: 66 
Age (years): Mean 62, SD 7 
Sex: M 32; F 34 
Prevalence of significant CAD: 
N/S 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
 
Arteries (n=245) 
Cutoff: > 50% stenosis  
Sensitivity: 95%  
Specificity: 96% 
PPV: 97%  
NPV: 92%  
 
Ghostine 2006[15] 
 
Country: France 
Enrolled: 66  
Analysed: 66 
Age (years): Mean 69, SD 13 
Machine: Sensation 64, Siemens  
Radiation dose: 7 (SD 2) mSv 
Dose modulation used: Yes 
Segments (n=94), patients (n=29) 
Cutoff: > 50% stenosis  
Sensitivity:  97%, 72%  
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Study id, country Participants 64-slice CT Outcomes summary 
 Sex: M 40; F 26 
Prevalence of significant CAD: 
44% (29/66) 
 
 
 
Specificity: 95%, 99%  
PPV: 93%, 91% 
NPV: 97%, 97%  
 
Hoffmann 2006[16] 
 
Country: USA 
 
Enrolled: 106  
Analysed: 103 (8 received both 
MSCT and invasive CA) 
Age (years): Mean 54, SD 12 
(whole group) 
Sex: M 62; F 41 (whole group) 
Prevalence of significant CAD: 
63% (5/8) 
 
Machine: Sensation 64, Siemens 
Radiation dose: 6 – 11 mSv 
Dose modulation used: Yes 
 
 
Patients (n=8) 
Cutoff: > 50% stenosis  
Sensitivity: 100% 
Specificity: 100% 
PPV: 100%  
NPV: 100% 
 
 
Johnson 2007[17] 
 
Country: Germany 
 
Enrolled: 55 
Analysed: 55 (20 received both 
CT and invasive CA) 
Age (years): N/S 
Sex: N/S 
Prevalence of significant CAD: 
85% (17/20) 
 
Machine: Sensation 64, Siemens 
Radiation dose: approximately 6.9 mSv 
Dose modulation used: Yes 
 
 
Patients (n=20) 
Cutoff: > 50% stenosis  
Sensitivity:  94%  
PPV: 84%  
Specificity and NPV: Not calculable (no 
true negatives) 
 
 23
Study id, country Participants 64-slice CT Outcomes summary 
Leber 2005[18] 
 
Country: Germany 
 
 
 
 
Enrolled: 59  
Analysed: 59 
Age (years):  
Mean 64, SD 10 
Sex: N/S 
Prevalence of significant CAD: 
42% (25/59) 
Machine: Sensation 64, Siemens 
Radiation dose: Mean 10 to 14 mSv 
Dose modulation used: Yes 
 
 
Segments (n=697), patients (n=55) 
Cutoff: > 50% stenosis  
Sensitivity:  73%, 88%  
Specificity: 97%, N/S  
PPV: 60%, N/S  
NPV: 98%, N/S  
 
 
Leschka 2005[19] 
 
Country: Switzerland 
 
 
 
Enrolled: 67  
Analysed: 67 
Age (years): Mean 60.1, SD 
10.5, range 34-82 
Sex: M 50; F 17 
Prevalence of significant CAD: 
70% (47/67) 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: No 
 
 
   
Segments (n=1005) 
Cutoff: > 50% stenosis  
Sensitivity: 94%  
Specificity: 97%  
PPV: 87%  
NPV: 99%  
 
Meijboom 2006[20] 
 
Country: The Netherlands 
 
Enrolled: 70  
Analysed: 70 
Age (years): Mean 63, SD 11 
Sex: M 49; F 21 
Prevalence of significant CAD: 
26% (18/70) 
Machine: Sensation 64, Siemens 
Radiation dose: 15.2 to 21.4 mSv for 
men and women, respectively 
Dose modulation used: No 
 
  
Segments (n=1003), patients (n=70) 
Cutoff: ≥ 50% stenosis  
Sensitivity: 94%, 100%  
Specificity: 98%, 92%  
PPV: 65%, 82%  
NPV: 100%, 100%  
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Mollet 2005[21] 
Country: The Netherlands 
Enrolled: 70  
Analysed: 52 
Age (years): Mean 59.6, SD 12.1 
Sex: M 34; F 18 
Prevalence of significant CAD: 
75% (39/52) 
Machine: Sensation 64, Siemens 
Radiation dose: 15.2 to 21.4 mSv for 
men and women, respectively 
Dose modulation used: No 
 
 
Segments (n=725), patients (n=51) 
Cutoff: ≥ 50% stenosis  
Sensitivity: 99%, 100%  
Specificity: 95%, 92%  
PPV: 76%, 97%  
NPV: 100%, 100%  
 
Nikolaou 2006[22] 
 
Country: Germany 
 
 
Enrolled: 72  
Analysed: 68 
Age (years): Mean 64, SD 10, 
range 38 to 89 
Sex: M 59; F 13 
Prevalence of significant CAD: 
57% (39/68) 
Machine: Sensation 64, Siemens 
Radiation dose: approximately 8 to 10 
mSv 
Dose modulation used: Yes 
 
 
Segments (n=923), patients (n=68) 
Cutoff: > 50% stenosis  
Sensitivity: 82%, 97%  
Specificity: 95%, 79%  
PPV: 69%, 86%  
NPV: 97%, 96%  
 
Ong 2006[23] 
 
Country: Malaysia  
 
 
 
Enrolled: 134  
Analysed: 134 
Age (years): Mean 54.5, SD 8.8 
Sex: M 98; F 36 
Prevalence of significant CAD: 
73% (98/134) 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: Yes 
 
 
Segments (n=68, group A), (n=66, group 
B) 
Cutoff: ≥ 50% stenosis  
Sensitivity: 85%, 80%   
Specificity: 98%, 93%  
PPV: 83%, 77%  
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NPV: 98%, 94%  
 
Pache 2006[24] 
 
Country: Germany 
 
Enrolled: 31  
Analysed: 31 
Age (years): Mean 68.4, SD 8.4, 
range 45 to 83 
Sex: M 26; F 5 
Prevalence of significant CAD: 
60% (24/31) 
 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: Yes 
 
 
Grafts (n=93), patients (n=31) 
Cutoff: > 50% stenosis  
Sensitivity: 98%, 100%  
Specificity: 89%, 71%  
PPV: 90%, 92%  
NPV: 98%, 100%  
 
Plass 2006[25] 
 
Country: Switzerland 
 
Enrolled: 50  
Analysed: 50 
Age (years): Mean 66, SD 8 
Sex: M 39; F 11 
Prevalence of significant CAD: 
80% (40/50) 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Segments (n=550), patients (n=50) 
Cutoff: > 50% stenosis  
Sensitivity: 87%, 100%  
Specificity: 96%, 90%  
PPV: 86%, 98%  
NPV: 96%, 100%  
 
Pugliese 2006a[26] 
 
Country: Italy 
 
Enrolled: 35  
Analysed: 35 
Age (years): Mean 61, SD 10, 
range 46 to 80 
Sex: M 21; F 14 
Machine: Sensation 64, Siemens 
Radiation dose: 15:20 mSv 
(male:female, respectively) 
Dose modulation used: No 
 
Segments (n=494), patients (n=35) 
Cutoff: ≥ 50% stenosis  
Sensitivity: 99%, 100%  
Specificity: 96%, 90%  
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 Prevalence of significant CAD: 
71% (25/35) 
 
 PPV: 78%, 96%  
NPV: 100%, 100%  
 
Raff 2005[27] 
 
Country: USA 
 
Enrolled: 70  
Analysed: 70 
Age (years): Mean 59, SD 11, 
range 22 to 81 
Sex: M 53; F 17 
Prevalence of significant CAD: 
57% (40/70) 
 
Machine: Sensation 64, Siemens 
Radiation dose: 13:18 mSv 
(men:women, respectively) 
Dose modulation used: No 
 
 
Segments (n=935), patients (n=70) 
Cutoff: ≥ 50% stenosis  
Sensitivity: 86%, 95%  
Specificity: 95%, 90%  
PPV: 66%, 93%  
NPV: 98%, 93%  
 
Rist 2006[28] 
Country: Germany 
 
 
Enrolled: 25  
Analysed: 25 
Age (years): Mean 59.4, SD 12, 
range 40 to 83 
Sex: M 23; F 2 
Prevalence of significant CAD: 
N/S  
 
Machine: Sensation 64, Siemens 
Radiation dose: 8-10 mSv 
Dose modulation used: Yes 
 
 
Stents (n=45) 
Cutoff: ≥ 50% stenosis  
Sensitivity: 75% 
Specificity: 92%  
PPV: 67%  
NPV: 94%  
 
Rixe 2006[29] 
 
Country: Germany 
Enrolled: 64  
Analysed: 64 
Age (years): Mean 58, SD 10 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: Yes 
Stents (n=59)  
Cutoff: > 50% stenosis  
Sensitivity: 86%  
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Sex: M 41; F 23 
Prevalence of significant CAD: 
N/S 
 
 
  
Specificity: 98% 
PPV: 86%  
NPV: 98% 
 
Ropers 2006a[30] 
 
Country: Germany 
 
 
Enrolled: 84  
Analysed: 81 
Age (years): Mean 58, SD 10, 
range 35 to 77 
Sex: N/S 
Prevalence of significant CAD: 
32% (26/81) 
 
Machine: Sensation 64, Siemens 
Radiation dose: average 7.45:10.24 mSv 
(men:women, respectively) 
Dose modulation used: Yes 
 
 
Segments (n=1083), patients (n=81) 
Cutoff: ≥ 50% stenosis  
Sensitivity: 93%, 96%  
Specificity: 97%, 91%  
PPV: 56%, 83%  
NPV: 100%, 98%  
 
 
Ropers 2006b[31] 
 
Country: Germany 
 
Enrolled: 50  
Analysed: 50 
Age (years): Mean 67, range 44 
to 82 
Sex: M 38; F 12 
Prevalence of significant CAD: 
N/S 
 
Machine: Sensation 64, Siemens 
Radiation dose: average 8.55:12.24 mSv 
(men:women, respectively) 
Dose modulation used: Yes 
 
 
Native segments (n=566), grafts (n=138) 
Cutoff: ≥ 50% stenosis  
Sensitivity: 86%; 100%  
Specificity: 76%; 94%  
PPV: 44%; 92% 
NPV: 96%; 100%  
 
Schuijf 2006[32] Enrolled: 61  Machine: Aquilion 64, Toshiba  Segments (n=842), patients (n=60) 
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Country: The Netherlands 
 
Analysed: 60 
Age (years): Mean 60, SD 11 
Sex: M 46; F 14 
Prevalence of significant CAD: 
52% (31/60) 
 
Radiation dose: N/S 
Dose modulation used: N/S 
 
Cutoff: ≥ 50% stenosis  
Sensitivity: 85%; 94%  
Specificity: 98%; 97%  
PPV: 82%; 97% 
NPV: 99%; 93%  
 
Sheth 2006[33] 
Country: USA 
 
Enrolled: 29  
Analysed: 29 
Age (years): Mean 60.3 
Sex: M 24; F 5 
Prevalence of significant CAD: 
N/S 
 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: N/S 
 
  
Segments, ≥1 feature of complexity 
(n=55) 
Cutoff: ≥ 1 criteria of complexity  
Sensitivity: 89%  
Specificity: 83%  
PPV: 82% 
NPV: 89%  
 
 
 29
(b) Abstracts 
 
Study id, country Participants Tests Outcomes summary 
Beck 2006[34] 
 
Country: Germany  
 
 
Enrolled: N/S  
Analysed: 102 
Age (years): 62, SD 10 
Sex: M 82; F 20  
Prevalence of significant CAD: 
N/S 
 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: N/S 
 
Segments (n=1326) 
Cutoff: > 50% stenosis  
Sensitivity: 90% 
Specificity: 99% 
PPV: 95% 
NPV: 98% 
 
Becker 2006[35] 
 
Country: Germany  
 
Enrolled: N/S  
Analysed: 199 
Age (years): 61.3, SD 12.6 
Sex: M 82; F 117  
Prevalence of significant CAD: 
59% (117/199) 
 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Patients (n=199) 
Cutoff: significant CAD  
Sensitivity: 97% 
Specificity: 79% 
PPV: 87% 
NPV: 94% 
 
 
Ehara 2006b[36] 
 
Country: Japan  
 
Enrolled: N/S  
Analysed: 80 
Age (years): 68 
Sex: M 62; F 18  
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: N/S 
 
Stents (n=113) 
Cutoff: > 50% stenosis  
Sensitivity: 95% 
Specificity: 90% 
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Prevalence of significant CAD: 
N/S 
 
 PPV: 70% 
NPV: 99% 
 
Fine 2006b[37] 
 
Country: USA  
 
 
Enrolled: N/S  
Analysed: 101 
Age (years): N/S 
Sex: N/S  
Prevalence of > 70% CAD: 41% 
(diabetes group), 33% (metabolic 
syndrome group), 15% 
(comparator group)  
 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Segments (n=N/S) 
Cutoff: > 70% stenosis  
Diabetes group, metabolic syndrome 
group, comparator group 
Sensitivity: 87%, 91%, 91% 
Specificity: 94%, 94%, 98% 
PPV: 87%, 87%, 93% 
NPV: 94%, 94%, 98% 
 
Hausleiter 2005[38] 
 
Country: Germany  
Enrolled: N/S  
Analysed: 43 
Age (years): N/S 
Sex: N/S  
Prevalence of significant CAD: 
N/S 
 
Machine: N/S 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Bypass grafts (n=130) 
Cutoff: ≥ 50% stenosis  
Sensitivity: 97% 
Specificity: 98% 
PPV: 95% 
NPV: 99% 
 
Makaryus 2006a[39] 
Country: USA  
Enrolled: 374  
Analysed: N/S 
Machine: GE Light-Speed VCT, GE 
Healthcare 
Unit of analysis: unclear 
Cutoff: > 50% stenosis  
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Age (years): N/S 
Sex: N/S 
Prevalence of significant CAD: 
N/S 
 
 
Radiation dose: N/S 
Dose modulation used: N/S 
 
Sensitivity: 88% 
Specificity: 97% 
PPV: N/S 
NPV: N/S 
Makaryus 2006b[40] 
 
Country: USA  
 
 
 
Enrolled: 18  
Analysed: 18 
Age (years): N/S 
Sex: N/S  
Prevalence of significant CAD: 
N/S 
 
 
Machine: GE Light-Speed VCT, GE 
Healthcare 
Radiation dose: N/S 
Dose modulation used: N/S 
 
Bypass grafts (n=43)  
Cutoff: > 50% stenosis  
Sensitivity: 90% 
Specificity: 97% 
PPV: N/S 
NPV: N/S 
 
Malagutti 2006[41] 
 
Country: The Netherlands 
 
 
Enrolled: N/S   
Analysed: 52 
Age (years): N/S 
Sex: N/S 
Prevalence of significant CAD: 
96% (50/52) 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: N/S 
Segments (n=182), patients (n=52) 
Cutoff: > 50% stenosis  
Sensitivity: 99%, 100% 
Specificity: 96%, 50% 
PPV: 95%, 98% 
NPV: 99%, 100% 
Oncel 2006[42] Enrolled: N/S Machine: Sensation 64, Siemens Stents (n=43) 
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Country: Turkey 
 
 
Analysed: 43 
Age (years): N/S 
Sex: N/S 
Prevalence of significant CAD: 
N/S 
 
Radiation dose: N/S 
Dose modulation used: N/S 
 
Cutoff: > 50% stenosis  
Sensitivity: 92% 
Specificity: 94% 
PPV: 96% 
NPV: 89% 
 
Onuma 2006[43] 
 
Country: Japan  
 
 
Enrolled: N/S  
Analysed: 29 
Age (years): N/S 
Sex: N/S  
Prevalence of significant CAD: 
N/S 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Segments (n=430) 
Cutoff: > 50% stenosis  
Sensitivity: 94% 
Specificity: 99% 
PPV: 93% 
NPV: 99% 
Pinto 2006[44] 
 
Country: Brazil 
Enrolled: N/S  
Analysed: 30 
Age (years): N/S 
Sex: N/S  
Prevalence of significant CAD: 
10% (3/30) 
 
Machine: N/S 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Stents (n=30) 
Cutoff: in-stent restenosis  
Sensitivity: 100% 
Specificity: N/S 
PPV: N/S 
NPV: N/S 
Pugliese 2006b[45] 
 
Enrolled: 51  
Analysed: 51 
Machine: N/S 
Radiation dose: N/S 
>2mm segments (n=N/S), all segments 
(n=N/S) 
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Country: The Netherlands Age (years): N/S 
Sex: N/S 
Prevalence of significant CAD: 
N/S 
 
Dose modulation used: N/S 
 
Cutoff: N/S  
Sensitivity: 99%, 99% 
Specificity: 96%, 95% 
PPV: 80%, 76% 
NPV: 99%, 99% 
 
Pugliese 2006c[46] 
 
Country: The Netherlands 
Enrolled: N/S  
Analysed: 25 
Age (years): N/S 
Sex: N/S  
Prevalence of significant CAD: 
96% (24/25) 
 
 
Machine: N/S 
Radiation dose: N/S 
Dose modulation used: N/S 
 
Patients (n=25) 
Cutoff: ≥ 1 vessel disease 
Sensitivity: 100% 
Specificity: 100% 
PPV: 100% 
NPV: 100% 
 
Rubinshtein 2006a[47] 
  
Country: Israel  
Enrolled: N/S  
Analysed: 133 
Age (years): 58.2, SD 11.8 
Sex: M 88; F 45 
Prevalence of significant CAD: 
30% (40/133) 
 
Machine: Brilliance 64, Philips 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Patients (n=133) 
Cutoff: ≥ 50% stenosis  
Sensitivity: 100% 
Specificity: 96%   
PPV: 91%   
NPV: 100%  
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Rubinshtein 2006b[48] 
 
Country: Israel 
Enrolled: N/S  
Analysed: 40 
Age (years): 59, SD 11 
Sex: M 24; F 16 
Prevalence of significant CAD: 
23% (9/40) 
 
Machine: Brilliance 64, Philips 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Stents (n=51), patients (n=40) 
Cutoff: > 50% stenosis  
Sensitivity: 100%, 100% 
Specificity: 88%, 84%  
PPV: 67%, 64% 
NPV: 100%, 100% 
 
Savino 2006[49] 
 
Country: USA  
 
Enrolled: N/S  
Analysed: 55 
Age (years): N/S 
Sex: N/S 
Prevalence of significant 
CAD:35% (19/55) 
 
Machine: N/S 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Segments (n=826), patients (n=55) 
Cutoff: > 50% stenosis  
Sensitivity: 82%, 100% 
Specificity: 97%, 83%  
PPV: 69%, 76% 
NPV: 99%, 100% 
 
Schlosser 2006[50] 
 
Country: Germany  
 
 
Enrolled: 179  
Analysed: 61 
Age (years): N/S 
Sex: N/S 
Prevalence of significant CAD: 
N/S   
 
Machine: N/S 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Segments (n=915) 
Cutoff: ≥ 50% stenosis  
Sensitivity: 100% 
Specificity: 97% 
PPV: 55% 
NPV: 100% 
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Sirol 2006[51] 
  
Country: Germany 
 
Enrolled: N/S 
Analysed: 38 
Age (years): 59, SD 14 
Sex: M 24, F 14 
Prevalence of significant CAD: 
N/S 
 
 
Machine: N/S 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Segments (n=521), patients (n=N/S) 
Cutoff: > 50% stenosis  
Sensitivity: 75%; 75% 
Specificity: 77%; 89% 
PPV: 88%; 88% 
NPV: 94%; 76% 
 
Wang 2006[52] 
 
Country: China  
 
 
Enrolled: 100  
Analysed: 48 
Age (years): N/S 
Sex: N/S 
Prevalence of significant CAD: 
N/S 
 
Machine: Sensation 64, Siemens 
Radiation dose: N/S 
Dose modulation used: N/S 
 
 
Arteries (n=192) 
Cutoff: > 50% stenosis  
Sensitivity: 95% 
Specificity: 93% 
PPV: 86% 
NPV: 98% 
 
 
Notes: 
1.  N/S, not stated. 
 
Supplementary material Table 2 Summary of diagnostic accuracy results for different 
levels of analysis  
 
Level of 
analysis 
Number 
of 
studies 
Number 
analysed 
Pooled 
sensitivity 
% (95% 
CrI) 
Pooled 
specificity 
% (95% 
CrI) 
PPV 
median 
% 
(range) 
NPV 
median 
% 
(range) 
Patient 18 1286 99 (97 to 99) 89 (83 to 94) 93 (64 to 
100) 
100 (86 
to 100) 
Segment 17 14199 90 (85 to 94) 97 (95 to 98) 76 (44 to 
93) 
99 (95 to 
100) 
Left main 
artery 
5 393 95 (84 to 99) 100 (99 to 
100) 
100 (90 
to 100) 
100 
LAD 
overall 
7 1685 92 (83 to 97) 96 (91 to 98) 86 (63 to 
100) 
98 (95 to 
100) 
LAD 
proximal 
5 358 97 (87 to 99) 97 (90 to 99) 95 (85 to 
100) 
98 (90 to 
100) 
LCX 
overall 
7 1351 85 (69 to 94) 96 (92 to 99) 81 (56 to 
100) 
98 (93 to 
100) 
RCA 
overall 
7 1567 87 (77 to 95) 97 (92 to 98) 82 (74 to 
91) 
98 (94 to 
100) 
Stents 6 317 89 (68 to 97) 94 (83 to 98) 77 (33 to 
100) 
96 (71 to 
100) 
CABGs 4 543 99 (95 to 
100) 
96 (86 to 99) 93 (90 to 
95) 
99 (98 to 
100) 
 
Notes: 
1. PPV, positive predictive value; NPV, negative predictive value; LAD, left anterior 
descending; LCX, left circumflex; CABG, coronary artery bypass graft. 
2. For left main artery analysis the 95% intervals around the pooled sensitivity and 
specificity estimates are confidence intervals (CIs) rather than credible intervals (CrIs).   
3. All five studies reporting left main artery analysis had an NPV of 100% 
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